Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Infectious Diseases Market by, Product and Services
6.1 Overview
6.2 Kits and Reagents
6.3 Instruments
6.4 Services
6.5 Software
6.6 Assays


7 Global Infectious Diseases Market by, Technology
7.1 Overview
7.2 Polymerase Chain Reaction (PCR)
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4 Immunodiagnostics
7.5 DNA Sequencing and Next-Generation Sequencing (NGS)
7.6 DNA Microarray
7.7 Clinical Microbiology
7.8 Other Technologies


8 Global Infectious Diseases Market by, Disease Type
8.1 Overview
8.2 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
8.3 Hepatitis
8.4 Hospital-Acquired Infections (HAIS)
8.5 Human Immunodeficiency Virus (HIV)
8.6 Human Papillomavirus (HPV)
8.7 Influenza
8.8 Tuberculosis (TB)
8.9 Other Disease Types


9 Global Infectious Diseases Market by, End User
9.1 Overview
9.2 Academic/Research Institutes
9.3 Hospital/Clinical Laboratories
9.4 Physician Offices
9.5 Reference Laboratories
9.6 Other End Users


10 Global Infectious Diseases Market by, Geography
10.1 Overview
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 New Zealand
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Qatar
10.6.4 Iran
10.6.5 South Africa
10.6.6 Rest of Middle East & Africa


11 Key Developments


12 Company Profiling
12.1 Abbott
12.1.1 Business Overview
12.1.2 Product/Service Offering
12.1.3 Financial Overview
12.1.4 SWOT Analysis
12.1.5 Key Activities
12.2 BD
12.3 bioM?rieux
12.4 Bio-Rad Laboratories Inc
12.5 Danaher
12.6 DiaSorin S.p.A
12.7 F. Hoffmann-La Roche Ltd
12.8 Johnson and Johnson Private Limited
12.9 Meridian Bioscience Inc
12.10 Quidel Corporation
12.11 Siemens
12.12 Thermo Fisher Scientific Inc